May be considered by a clinician for a defined condition after standard options, evidence quality and the patient’s medication history are reviewed.
LONGEVITY & HEALTHY AGING / PRACTITIONER-GUIDED
Low-dose naltrexone (LDN)
Low-dose naltrexone is an off-label approach discussed for selected chronic pain and inflammatory conditions, with evidence that varies substantially by condition.Create account & prepare for review →Practitioner review required · A prescription is never guaranteed.
Limited and condition-specific human evidence; no broad wellness or longevity indication is established.
Naltrexone is FDA-approved at other doses; low-dose use is off-label
WHO MAY BE CONSIDERED
Eligibility starts with your complete health context.
- ✓A specific clinical goal is documented
- ✓Opioid exposure and withdrawal risk are fully reviewed
- ✓The patient understands the off-label evidence limits
WHAT A PRACTITIONER REVIEWS
The information that shapes the decision.
- →All opioid, tramadol and cough or diarrhea medicines
- →Liver history and relevant labs
- →Pain, sleep, mood and a defined trial outcome
IMPORTANT SAFETY INFORMATION
Reasons treatment may not be appropriate.
- !Naltrexone can precipitate opioid withdrawal and block opioid pain treatment.
- !Liver disease and medication interactions require review.
- !LDN should not be marketed as a cure-all or substituted for diagnosis and established care.
ORIGINAL SOURCES